|
Name |
Leptosidin
|
Molecular Formula | C16H12O6 | |
IUPAC Name* |
(2Z)-2-[(3,4-dihydroxyphenyl)methylidene]-6-hydroxy-7-methoxy-1-benzofuran-3-one
|
|
SMILES |
COC1=C(C=CC2=C1O/C(=C\C3=CC(=C(C=C3)O)O)/C2=O)O
|
|
InChI |
InChI=1S/C16H12O6/c1-21-16-11(18)5-3-9-14(20)13(22-15(9)16)7-8-2-4-10(17)12(19)6-8/h2-7,17-19H,1H3/b13-7-
|
|
InChIKey |
PFRGTMTYWMVLMU-QPEQYQDCSA-N
|
|
Synonyms |
Leptosidin; 486-24-8; VE67J9PR82; 3(2H)-Benzofuranone, 2-(3,4-dihydroxybenzylidene)-6-hydroxy-7-methoxy-; C08651; (Z)-2-((3,4-Dihydroxyphenyl)methylene)-6-hydroxy-7-methoxy-3(2H)-benzofuranone; 3(2H)-Benzofuranone, 2-((3,4-dihydroxyphenyl)methylene)-6-hydroxy-7-methoxy-, (Z)-; AC1NQYAI; SureCN6804084; UNII-VE67J9PR82; CHEBI:6412; SCHEMBL6804084; CHEMBL3799890; DTXSID501028834; ZINC4642934; Q6528333; (2Z)-2-((3,4-DIHYDROXYPHENYL)METHYLENE)-6-HYDROXY-7-METHOXY-3(2H)-BENZOFURANONE; (2Z)-2-[(3,4-dihydroxyphenyl)methylene]-6-hydroxy-7-methoxy-benzofuran-3-one; (2Z)-2-[(3,4-dihydroxyphenyl)methylidene]-6-hydroxy-7-methoxy-1-benzofuran-3(2H)-one; 2-(3,4-Dihydroxybenzylidene)-6-hydroxy-7-methoxy-2,3-dihydrobenzofuran-3-one
|
|
CAS | 486-24-8 | |
PubChem CID | 5281257 | |
ChEMBL ID | CHEMBL3799890 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 300.26 | ALogp: | 2.5 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 96.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 22 | QED Weighted: | 0.582 |
Caco-2 Permeability: | -5.027 | MDCK Permeability: | 0.00001850 |
Pgp-inhibitor: | 0.138 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.022 | 20% Bioavailability (F20%): | 0.489 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.055 | Plasma Protein Binding (PPB): | 99.45% |
Volume Distribution (VD): | 0.45 | Fu: | 2.08% |
CYP1A2-inhibitor: | 0.947 | CYP1A2-substrate: | 0.306 |
CYP2C19-inhibitor: | 0.171 | CYP2C19-substrate: | 0.057 |
CYP2C9-inhibitor: | 0.606 | CYP2C9-substrate: | 0.437 |
CYP2D6-inhibitor: | 0.216 | CYP2D6-substrate: | 0.241 |
CYP3A4-inhibitor: | 0.495 | CYP3A4-substrate: | 0.198 |
Clearance (CL): | 8.579 | Half-life (T1/2): | 0.893 |
hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.179 |
Drug-inuced Liver Injury (DILI): | 0.546 | AMES Toxicity: | 0.61 |
Rat Oral Acute Toxicity: | 0.961 | Maximum Recommended Daily Dose: | 0.916 |
Skin Sensitization: | 0.927 | Carcinogencity: | 0.747 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.937 |
Respiratory Toxicity: | 0.279 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003373 | 0.506 | D04AIT | 0.368 | ||||
ENC005410 | 0.488 | D0K8KX | 0.360 | ||||
ENC003492 | 0.444 | D07MGA | 0.341 | ||||
ENC002823 | 0.424 | D0V9EN | 0.333 | ||||
ENC001998 | 0.419 | D0U3YB | 0.330 | ||||
ENC002756 | 0.413 | D06GCK | 0.313 | ||||
ENC002125 | 0.413 | D0E9CD | 0.300 | ||||
ENC005040 | 0.406 | D08SKH | 0.289 | ||||
ENC001573 | 0.402 | D0AZ8C | 0.282 | ||||
ENC005411 | 0.400 | D0J7RK | 0.281 |